Biologics processes continue to evolve after approval. This guide explains how ICH Q12 uses Established Conditions, PACMPs, PLCM documents, and the PQS to make post-approval CMC changes more predictable and risk-based.

Biologics CMC Regulatory Framework: Executive Summary If you only have three minutes, remember these five points: Biologics CMC is not a single regulation. It is a lifecycle framework connecting the product, manufacturing process, analytical methods, control strategy, and pharmaceutical quality system. ICH provides a shared scientific language. FDA and European authorities apply those principles through their own laws, submission pathways, and post-approval change procedures.